Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency

被引:91
作者
Kang-Decker, N
Tong, CL
Boussouar, F
Baker, DJ
Xu, W
Leontovich, AA
Taylor, WR
Brindle, PK
van Deursen, JMA
机构
[1] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA
[4] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
关键词
D O I
10.1016/S1535-6108(04)00022-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CBP can function as a tumor suppressor, but the mechanisms that govern oncogenesis in its absence are unknown. Here we show that CBP inactivation in mouse thymocytes leads to lymphoma. Although CBP has been implicated in the transactivation functions of p53, development of these tumors does not seem to involve loss of p53 activity. CBP-null tumors show reduced levels of P27(Kip1) and increased levels of cyclin E andSkp2, two oncoproteins that can promote p27(Kip1) proteolysis. Reduction of p27(Kip1) by introduction of a p27(Kip1)-null allele into CBP knockout mice accelerates lymphomagenesis and seems to obviate the requirement for Skp2 and cyclin E upregulation. These data suggest that CBP loss mediates lymphomagenesis in cooperation with a mechanism that reduces p27(Kip1) abundance.
引用
收藏
页码:177 / 189
页数:13
相关论文
共 51 条
[1]   Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian Polycomb complex [J].
Alkema, MJ ;
Bronk, M ;
Verhoeven, E ;
Otte, A ;
vantVeer, LT ;
Berns, A ;
vanLohuizen, M .
GENES & DEVELOPMENT, 1997, 11 (02) :226-240
[2]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[3]   p27 as a target for cancer therapeutics [J].
Blain, SW ;
Scher, HI ;
Cordon-Cardo, C ;
Koff, A .
CANCER CELL, 2003, 3 (02) :111-115
[4]   CREB-binding protein and p300: molecular integrators of hematopoietic transcription [J].
Blobel, GA .
BLOOD, 2000, 95 (03) :745-755
[5]   Deregulated degradation of the cdk inhibitor p27 and malignant transformation [J].
Bloom, J ;
Pagano, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :41-47
[6]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[7]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[8]  
Chernesky R H, 1999, Care Manag J, V1, P19
[9]   MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP [J].
Deguchi, K ;
Ayton, PM ;
Carapeti, M ;
Kutok, JL ;
Snyder, CS ;
Williams, IR ;
Cross, NCP ;
Glass, CK ;
Cleary, ML ;
Gilliland, DG .
CANCER CELL, 2003, 3 (03) :259-271
[10]  
Erlanson M, 1998, BLOOD, V92, P770